Drury A, Szent-Györgyi A (1929) The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J Physiol 68:213–237
Burnstock G (1978) A basis for distinguishing two types of purinergic receptor. In: Straub RW (ed) Cell membrane receptors for drugs and hormones: a multidisciplinary approach. Raven, New York, pp 107–118
Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24:509–581
Burnstock G (1997) The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 36:1127–1139
Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413–492
Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659–797
Gordon JL (1986) Extracellular ATP: effects, sources and fate. Biochem J 233:309–319
Zimmermann H (2006) Ectonucleotidases in the nervous system. Novartis Found Symp 276:113–128
Burnstock G, Kennedy C (1986) A dual function for adenosine 5’-triphosphate in the regulation of vascular tone. Excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent. Circ Res 58:319–330
Olsson RA, Pearson JD (1990) Cardiovascular purinoceptors. Physiol Rev 70:761–845
Ralevic V, Burnstock G (1991) Roles of P2-purinoceptors in the cardiovascular system. Circulation 84:1–14
Erlinge D (1998) Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen Pharmacol 31:1–8
Burnstock G (2002) Purinergic signalling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 22:364–373
Di Virgilio F, Solini A (2002) P2 receptors: new potential players in atherosclerosis. Br J Pharmacol 135:831–842
Gachet C (2006) Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol 46:277–300
Agteresch HJ, Dagnelie PC, van den Berg JW et al (1999) Adenosine triphosphate: established and potential clinical applications. Drugs 58:211–232
Ralevic V, Burnstock G (2003) Involvement of purinergic signaling in cardiovascular diseases. Drug News Perspect 16:133–140
Atkinson B, Dwyer K, Enjyoji K et al (2006) Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: potential as therapeutic targets. Blood Cells Mol Dis 36:217–222
Burnstock G (2006) Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58:58–86
Burnstock G (1976) Do some nerve cells release more than one transmitter? Neuroscience 1:239–248
Burnstock G (1988) Sympathetic purinergic transmission in small blood vessels. Trends Pharmacol Sci 9:116–117
Burnstock G (1987) Local control of blood pressure by purines. Blood Vessels 24:156–160
Burnstock G (1988) Local purinergic regulation of blood pressure (The First John T. Shepherd Lecture). In: Vanhoutte PM (ed) Vasodilatation: vascular smooth muscle, peptides, autonomic nerves, and endothelium. Raven, New York, pp 1–14
Burnstock G (1990) Local mechanisms of blood flow control by perivascular nerves and endothelium. J Hypertens Suppl 8:S95–S106
Burnstock G (1990) Noradrenaline and ATP as cotransmitters in sympathetic nerves. Neurochem Int 17:357–368
Burnstock G (1996) A unifying purinergic hypothesis for the initiation of pain. Lancet 347:1604–1605
Burnstock G (1993) Introduction: changing face of autonomic and sensory nerves in the circulation. In: Edvinsson L, Uddman R (eds) Vascular innervation and receptor mechanisms: new perspectives. Academic, New York, pp 1–22
Rubino A, Burnstock G (1996) Capsaicin-sensitive sensory-motor neurotransmission in the peripheral control of cardiovascular function. Cardiovasc Res 31:467–479
Vial C, Evans RJ (2002) P2X1 receptor-deficient mice establish the native P2X receptor and a P2Y6-like receptor in arteries. Mol Pharmacol 62:1438–1445
Ramme D, Regenold JT, Starke K et al (1987) Identification of the neuroeffector transmitter in jejunal branches of the rabbit mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol 336:267–273
Chan CM, Unwin RJ, Bardini M et al (1998) Localization of P2X1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys. Am J Physiol 274:F799–F804
Inscho EW, Cook AK, Imig JD et al (2004) Renal autoregulation in P2X1 knockout mice. Acta Physiol Scand 181:445–453
Inscho EW, Cook AK, Imig JD et al (2003) Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. J Clin Invest 112:1895–1905
Boehm S, Huck S (1997) Receptors controlling transmitter release from sympathetic neurons in vitro. Prog Neurobiol 51:225–242
Cunha R (2001) Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem Int 38:107–125
Todorov LD, Mihaylova-Todorova S, Westfall TD et al (1997) Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature 387:76–79
Rosenmeier JB, Hansen J, Gonzalez-Alonso J (2004) Circulating ATP-induced vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal muscle. J Physiol 558:351–365
Burnstock G, Kennedy C (1985) Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 16:433–440
Lewis CJ, Evans RJ (2000) Comparison of P2X receptors in rat mesenteric, basilar and septal (coronary) arteries. J Auton Nerv Syst 81:69–74
Wang L, Karlsson L, Moses S et al (2002) P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 40:841–853
von Kügelgen I, Haussinger D, Starke K (1987) Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery. Naunyn Schmiedebergs Arch Pharmacol 336:556–560
Malmsjö M, Adner M, Harden TK et al (2000) The stable pyrimidines UDPβS and UTPγS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery. Br J Pharmacol 131:51–56
Sévigny J et al (2006) Co-ordinated regulation of P2-receptor signaling by membrane bound NTPDases. Purinergic Signalling 2:53
Borna C, Wang L, Gudbjartsson T et al (2003) Contractions in human coronary bypass vessels stimulated by extracellular nucleotides. Ann Thorac Surg 76:50–57
Brinson AE, Harden TK (2001) Differential regulation of the uridine nucleotide-activated P2Y4 and P2Y6 receptors. SER-333 and SER-334 in the carboxyl terminus are involved in agonist-dependent phosphorylation desensitization and internalization of the P2Y4 receptor. J Biol Chem 276:11939–11948
Wihlborg AK, Wang L, Braun OO et al (2004) ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arterioscler Thromb Vasc Biol 24:1810–1815
Burnstock G (1999) Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 194:335–342
Malmsjö M, Edvinsson L, Erlinge D (1998) P2U-receptor mediated endothelium-dependent but nitric oxide-independent vascular relaxation. Br J Pharmacol 123:719–729
Malmsjö M, Erlinge D, Högestätt ED et al (1999) Endothelial P2Y receptors induce hyperpolarisation of vascular smooth muscle by release of endothelium-derived hyperpolarising factor. Eur J Pharmacol 364:169–173
Mistry H, Gitlin JM, Mitchell JA et al (2003) Endothelium-dependent relaxation and endothelial hyperpolarization by P2Y receptor agonists in rat-isolated mesenteric artery. Br J Pharmacol 139:661–671
Hrafnkelsdottir T, Erlinge D, Jern S (2001) Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man. Thromb Haemost 85:875–881
Wihlborg AK, Malmsjö M, Eyjolfsson A et al (2003) Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium-derived hyperpolarising factor. Br J Pharmacol 138:1451–1458
Guns PJ, Korda A, Crauwels HM et al (2005) Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta. Br J Pharmacol 146:288–295
Yamamoto K, Korenaga R, Kamiya A et al (2000) P2X4 receptors mediate ATP-induced calcium influx in human vascular endothelial cells. Am J Physiol Heart Circ Physiol 279:H285–H292
Yamamoto K, Korenaga R, Kamiya A et al (2000) Fluid shear stress activates Ca2+ influx into human endothelial cells via P2X4 purinoceptors. Circ Res 87:385–391
Bodin P, Bailey D, Burnstock G (1991) Increased flow-induced ATP release from isolated vascular endothelial cells but not smooth muscle cells. Br J Pharmacol 103:1203–1205
Yamamoto K, Sokabe T, Matsumoto T et al (2006) Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med 12:133–137
Kaczmarek E, Koziak K, Sévigny J et al (1996) Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem 271:33116–33122
Yegutkin G, Bodin P, Burnstock G (2000) Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5’-nucleotidase along with endogenous ATP from vascular endothelial cells. Br J Pharmacol 129:921–926
Vassort G (2001) Adenosine 5’-triphosphate: a P2-purinergic agonist in the myocardium. Physiol Rev 81:767–806
Saito D, Steinhart CR, Nixon DC et al (1981) Intracoronary adenosine deaminase reduces canine myocardial reactive hyperemia. Circ Res 49:1262–1267
Zatta AJ, Headrick JP (2005) Mediators of coronary reactive hyperaemia in isolated mouse heart. Br J Pharmacol 144:576–587
Olivecrona GK et al (2006) Coronary artery reperfusion: the ADP receptor P2Y1 mediates early reactive hyperemia in vivo in pigs. Purinergic Signalling 1:59–64
Ellsworth ML, Forrester T, Ellis CG et al (1995) The erythrocyte as a regulator of vascular tone. Am J Physiol 269:H2155–H2161
McMahon TJ, Moon RE, Luschinger BP et al (2002) Nitric oxide in the human respiratory cycle. Nat Med 8:711–717
Cosby K, Partovi KS, Crawford JH et al (2003) Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9:1498–1505
Bergfeld GR, Forrester T (1992) Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 26:40–47
Sprague RS (2001) Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation to ATP release. Am J Physiol Cell Physiol 281:C1158–C1164
Sprague RS, Stephenson AH, Ellsworth ML et al (2001) Impaired release of ATP from red blood cells of humans with primary pulmonary hypertension. Exp Biol Med (Maywood) 226:434–439
Dietrich HH, Ellsworth ML, Sprague RS et al (2000) Red blood cell regulation of microvascular tone through adenosine triphosphate. Am J Physiol Heart Circ Physiol 278:H1294–H1298
Gonzalez-Alonso J, Olsen DB, Saltin B (2002) Erythrocyte and the regulation of human skeletal muscle blood flow and oxygen delivery: role of circulating ATP. Circ Res 91:1046–1055
Farias M, Gorman MW, Savage MV et al (2005) Plasma ATP during exercise: possible role in regulation of coronary blood flow. Am J Physiol Heart Circ Physiol 288:H1586–H1590
Wang L, Olivecrona G, Götberg M et al (2005) ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells. Circ Res 96:189–196
Olearczyk JJ, Ellsworth ML, Stephenson AH et al (2004) Nitric oxide inhibits ATP release from erythrocytes. J Pharmacol Exp Ther 309:1079–1084
Trams EJ, Kauffman H, Burnstock G (1980) A proposal for the role of ecto-enzymes and adenylates in traumatic shock. J Theor Biol 87:609–621
Sluyter R, Shemon AN, Barden JA et al (2004) Extracellular ATP increases cation fluxes in human erythrocytes by activation of the P2X7 receptor. J Biol Chem 279:44749–44755
Bodin P, Burnstock G (1996) ATP-stimulated release of ATP by human endothelial cells. J Cardiovasc Pharmacol 27:872–875
Tanneur V, Duranton C, Brand VB (2006) Purinoceptors are involved in the induction of an osmolyte permeability in malaria-infected and oxidized human erythrocytes. FASEB J 20:133–135
Locovei S, Bao L, Dahl G (2006) Pannexin 1 in erythrocytes: function without a gap. Proc Natl Acad Sci USA 103:7655–7659
Vidal M, Hicks PE, Langer SZ (1986) Differential effects of α-β-methylene ATP on responses to nerve stimulation in SHR and WKY tail arteries. Naunyn Schmiedebergs Arch Pharmacol 332:384–390
Brock JA, Van Helden DF (1995) Enhanced excitatory junction potentials in mesenteric arteries from spontaneously hypertensive rats. Pflugers Arch 430:901–908
Fernandez O, Wangensteen R, Osuna A et al (2000) Renal vascular reactivity to P2-purinoceptor activation in spontaneously hypertensive rats. Pharmacology 60:47–50
Galligan JJ, Hess MC, Miller SB et al (2001) Differential localization of P2 receptor subtypes in mesenteric arteries and veins of normotensive and hypertensive rats. J Pharmacol Exp Ther 296:478–485
Yang D, Gluais P, Zhang JN et al (2004) Endothelium-dependent contractions to acetylcholine, ATP and the calcium ionophore A 23187 in aortas from spontaneously hypertensive and normotensive rats. Fundam Clin Pharmacol 18:321–326
Vonend O, Turner CM, Chan CM et al (2004) Glomerular expression of the ATP-sensitive P2X receptor in diabetic and hypertensive rat models. Kidney Int 66:157–166
Schluter H, Offers E, Brüggemann G et al (1994) Diadenosine phosphates and the physiological control of blood pressure. Nature 367:186–188
Hollah P, Hausberg M, Kosch M et al (2001) A novel assay for determination of diadenosine polyphosphates in human platelets: studies in normotensive subjects and in patients with essential hypertension. J Hypertens 19:237–245
Jankowski V, Tölle M, Vanholder R et al (2005) Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor. Nat Med 11:223–227
Roberts VH, Webster RP, Brockman DE et al (2006) Post-translational modifications of the P2X4 purinergic receptor subtype in the human placenta are altered in preeclampsia. Placenta 28:270–277
Sprague RS, Olearczyk JJ, Spence DM et al (2003) Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance. Am J Physiol Heart Circ Physiol 285:H693–H700
Greenberg B, Rhoden K, Barnes PJ (1987) Endothelium-dependent relaxation of human pulmonary arteries. Am J Physiol 252:H434–H438
Zhang S, Remillard CV, Fantozzi I et al (2004) ATP-induced mitogenesis is mediated by cyclic AMP response element-binding protein-enhanced TRPC4 expression and activity in human pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol 287:C1192–C1201
Malmsjö M, Hou M, Pendergast W et al (2003) Potent P2Y6 receptor mediated contractions in human cerebral arteries. BMC Pharmacol 3:4
Burnstock G (1989) The role of adenosine triphosphate in migraine. Biomed Pharmacother 43:727–736
Waeber C, Moskowitz MA (2003) Therapeutic implications of central and peripheral neurologic mechanisms in migraine. Neurology 61:S9–S20
Fabbretti E, D’Arco M, Fabbro A et al (2006) Delayed upregulation of ATP P2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide. J Neurosci 26:6163–6171
Peroutka SJ (2004) Migraine: a chronic sympathetic nervous system disorder. Headache 44:53–64
Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695
Hashimoto M, Shinozuka K, Shahdat HM et al (1998) Antihypertensive effect of all-cis-5,8,11,14,17-icosapentaenoate of aged rats is associated with an increase in the release of ATP from the caudal artery. J Vasc Res 35:55–62
Hashimoto M, Shinozuka K, Tanabe Y et al (1998) Long-term supplementation with a high cholesterol diet decreases the release of ATP from the caudal artery in aged rats. Life Sci 63:1879–1885
Karoon P, Burnstock G (1998) Reduced sympathetic noradrenergic neurotransmission in the tail artery of Donryu rats fed with high cholesterol-supplemented diet. Br J Pharmacol 123:1016–1021
Di Virgilio F, Chiozzi P, Ferrari D et al (2001) Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97:587–600
Wang L, Jacobsen SE, Bengtsson A et al (2004) P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol 5:16
Baricordi OR, Ferrari D, Melchiorri L et al (1996) An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood 87:682–690
Kawamura H, Aswad F, Minagawa M et al (2005) P2X7 receptor-dependent and -independent T cell death is induced by nicotinamide adenine dinucleotide. J Immunol 174:1971–1979
Ferrari D, Chiozzi P, Falzoni S et al (1997) Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159:1451–1458
Suzuki T, Hide I, Ido K et al (2004) Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J Neurosci 24:1–7
Gu B, Bendall LJ, Wiley JS (1998) Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood 92:946–951
Labasi JM, Petrushova N, Donovan C et al (2002) Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 168:6436–6445
Idzko M, Dichmann S, Ferrari D et al (2002) Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood 100:925–932
Schmid-Antomarchi H, Schmid-Alliana A, Romey G et al (1997) Extracellular ATP and UTP control the generation of reactive oxygen intermediates in human macrophages through the opening of a charybdotoxin-sensitive Ca2+-dependent K+ channel. J Immunol 159:6209–6215
Hechler B et al (2006) Reduced atherosclerotic lesions in P2Y1/ApoE double knockout mice. Purinergic Signalling 2:299
Duhant X, Schandené L, Bruyns C et al (2002) Extracellular adenine nucleotides inhibit the activation of human CD4+ T lymphocytes. J Immunol 169:15–21
Kaufmann A, Musset B, Limberg SH et al (2005) “Host tissue damage” signal ATP promotes non-directional migration and negatively regulates toll-like receptor signaling in human monocytes. J Biol Chem 280:32459–32467
Marteau F, Gonzalez NS, Communi D et al (2005) Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells. Blood 106:3860–3866
Amisten S, Melander O, Wihlborg AK et al (2006) Increased risk of acute myocardial infarction and elevated levels of C-reactive protein in carriers of the Thr-87 variant of the ATP receptor P2Y11. Eur Heart J 28:13–18
Dawicki DD, McGowan-Jordan J, Bullard S et al (1995) Extracellular nucleotides stimulate leukocyte adherence to cultured pulmonary artery endothelial cells. Am J Physiol 268:L666–L673
Seiffert K, Ding W, Wagner JA et al (2006) ATPγS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling. J Invest Dermatol 126:1017–1027
Seye CI, Yu N, Jain R et al (2003) The P2Y2 nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells. J Biol Chem 278:24960–24965
Seye CI, Yu N, González FA et al (2004) The P2Y2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1). J Biol Chem 279:35679–35686
Seye CI, Kong Q, Erb L et al (2002) Functional P2Y2 nucleotide receptors mediate uridine 5’-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries. Circulation 106:2720–2726
Hart MN, Heistad DD, Brody MJ (1980) Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels. Hypertension 2:419–423
Erlinge D, Yoo H, Edvinsson L et al (1993) Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters. Am J Physiol 265:H1089–H1097
Wang DJ, Huang NN, Heppel LA (1992) Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells. J Cell Physiol 153:221–233
Malam-Souley R, Seye C, Gadeau AP et al (1996) Nucleotide receptor P2u partially mediates ATP-induced cell cycle progression of aortic smooth muscle cells. J Cell Physiol 166:57–65
Erlinge D, You J, Wahlestedt C et al (1995) Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells. Eur J Pharmacol 289:135–149
Hou M, Harden TK, Kuhn CM et al (2002) UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y6 receptors. Am J Physiol Heart Circ Physiol 282:H784–H792
Wilden PA, Agazie YM, Kaufman R et al (1998) ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways. Am J Physiol 275:H1209–H1215
Sauzeau V, Le Jeune H, Cario-Toumaniantz C et al (2000) P2Y1, P2Y2, P2Y4, and P2Y6 receptors are coupled to Rho and Rho kinase activation in vascular myocytes. Am J Physiol Heart Circ Physiol 278:H1751–H1761
Miyagi Y, Kobayashi S, Ahmed A et al (1996) P2U purinergic activation leads to the cell cycle progression from the G1 to the S and M phases but not from the G0 to G1 phase in vascular smooth muscle cells in primary culture. Biochem Biophys Res Commun 222:652–658
Erlinge D, Brunkwall J, Edvinsson L (1994) Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP. Regul Pept 50:259–265
Erb L, Liu J, Ockerhausen J et al (2001) An RGD sequence in the P2Y2 receptor interacts with αVβ3 integrins and is required for Go-mediated signal transduction. J Cell Biol 153:491–501
Robinson WP 3rd, Douillet CD, Milano PM et al (2006) ATP stimulates MMP-2 release from human aortic smooth muscle cells via JNK signaling pathway. Am J Physiol Heart Circ Physiol 290:H1988–H1996
Chaulet H, Desgranges C, Renault MA et al (2001) Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin. Circ Res 89:772–778
Koziak K et al (2006) Adenovirus-mediated over-expression of CD39 inhibits neointima formation in rat aorta. Purinergic Signalling 2:Addendum
Imai M, Takigami K, Guckelberger O et al (1999) Modulation of nucleoside triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection. Mol Med 5:743–752
Pillois X, Chaulet H, Belloc I et al (2002) Nucleotide receptors involved in UTP-induced rat arterial smooth muscle cell migration. Circ Res 90:678–681
Ralevic V, Belai A, Burnstock G (1995) Effects of streptozotocin-diabetes on sympathetic nerve, endothelial and smooth muscle function in the rat mesenteric arterial bed. Eur J Pharmacol 286:193–199
Gür S, Ozturk B (2000) Altered relaxant responses to adenosine and adenosine 5’-triphosphate in the corpus cavernosum from men and rats with diabetes. Pharmacology 60:105–112
Sprague RS, Stephenson AH, Bowles EA et al (2006) Reduced expression of Gi in erythrocytes of humans with type 2 diabetes is associated with impairment of both cAMP generation and ATP release. Diabetes 55:3588–3593
Parodi J, Flores C, Aguayo C et al (2002) Inhibition of nitrobenzylthioinosine-sensitive adenosine transport by elevated D-glucose involves activation of P2Y2 purinoceptors in human umbilical vein endothelial cells. Circ Res 90:570–577
Hellman B, Dansk H, Grapengiesser E (2004) Pancreatic β-cells communicate via intermittent release of ATP. Am J Physiol Endocrinol Metab 286:E759–E765
Nilsson J, Nilsson LM, Chen YW et al (2006) High glucose activates nuclear factor of activated T cells in native vascular smooth muscle. Arterioscler Thromb Vasc Biol 26:794–800
Pacaud P, Malam-Souley R, Loirand G et al (1995) ATP raises [Ca2+]i via different P2-receptor subtypes in freshly isolated and cultured aortic myocytes. Am J Physiol 269:H30–H36
Erlinge D, Hou M, Webb TE et al (1998) Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. Biochem Biophys Res Commun 248:864–870
Hou M, Möller S, Edvinsson L et al (1999) MAPKK-dependent growth factor-induced upregulation of P2Y2 receptors in vascular smooth muscle cells. Biochem Biophys Res Commun 258:648–652
Hou M, Möller S, Edvinsson L et al (2000) Cytokines induce upregulation of vascular P2Y2 receptors and increased mitogenic responses to UTP and ATP. Arterioscler Thromb Vasc Biol 20:2064–2069
Seye CI, Gadeau AP, Daret D et al (1997) Overexpression of P2Y2 purinoceptor in intimal lesions of the rat aorta. Arterioscler Thromb Vasc Biol 17:3602–3610
Shen J, Seye CI, Wang M et al (2004) Cloning, up-regulation, and mitogenic role of porcine P2Y2 receptor in coronary artery smooth muscle cells. Mol Pharmacol 66:1265–1274
Hogarth DK, Sandbo N, Taurin S et al (2004) Dual role of PKA in phenotypic modulation of vascular smooth muscle cells by extracellular ATP. Am J Physiol Cell Physiol 287:C449–C456
Wang L, Andersson M, Karlsson L et al (2003) Increased mitogenic and decreased contractile P2 receptors in smooth muscle cells by shear stress in human vessels with intact endothelium. Arterioscler Thromb Vasc Biol 23:1370–1376
Van Daele P, Van Coevorden A, Roger PP et al (1992) Effects of adenine nucleotides on the proliferation of aortic endothelial cells. Circ Res 70:82–90
Kaczmarek E, Erb L, Koziak K et al (2005) Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways. Thromb Haemost 93:735–742
Gerasimovskaya EV, Davie NJ, Ahmad S et al (2005) Extracellular adenosine triphosphate: a potential regulator of vasa vasorum neovascularization in hypoxia-induced pulmonary vascular remodeling. Chest 128(6 Suppl):608S–610S
Eltzschig HK, Ibla JC, Furuta GT (2003) Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med 198:783–796
Goepfert C, Sundberg C, Sévigny J et al (2001) Disordered cellular migration and angiogenesis in cd39-null mice. Circulation 104:3109–3115
Cario-Toumaniantz C, Loirand G, Ladoux A et al (1998) P2X7 receptor activation-induced contraction and lysis in human saphenous vein smooth muscle. Circ Res 83:196–203
Metcalfe MJ, Baker DM, Burnstock G (2006) Purinoceptor expression on keratinocytes reflects their function in the epidermis during chronic venous insufficiency. Arch Dermatol Res 298:301–307
Clemens MG, Forrester T (1981) Appearance of adenosine triphosphate in the coronary sinus effluent from isolated working rat heart in response to hypoxia. J Physiol 312:143–158
Bogdanov Y, Rubino A, Burnstock G (1998) Characterisation of subtypes of the P2X and P2Y families of ATP receptors in the foetal human heart. Life Sci 62:697–703
Wihlborg AK, Balogh J, Wang L et al (2006) Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction. Circ Res 98:970–976
Danziger RS, Raffaeli S, Moreno-Sanchez R et al (1988) Extracellular ATP has a potent effect to enhance cytosolic calcium and contractility in single ventricular myocytes. Cell Calcium 9:193–199
Zheng JS, Boluyt MO, Long X et al (1996) Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes. Circ Res 78:525–535
Podrasky E, Xu D, Liang BT (1997) A novel phospholipase C- and cAMP-independent positive inotropic mechanism via a P2 purinoceptor. Am J Physiol 273:H2380–H2387
Mei Q, Liang BT (2001) P2 purinergic receptor activation enhances cardiac contractility in isolated rat and mouse hearts. Am J Physiol Heart Circ Physiol 281:H334–H341
Froldi G, Pandolfo L, Chinellato A et al (1994) Dual effect of ATP and UTP on rat atria: which types of receptors are involved? Naunyn Schmiedebergs Arch Pharmacol 349:381–386
Scamps F, Vassort G (1994) Pharmacological profile of the ATP-mediated increase in L-type calcium current amplitude and activation of a non-specific cationic current in rat ventricular cells. Br J Pharmacol 113:982–986
Vahlensieck U, Bokník P, Gombosová I et al (1999) Inotropic effects of diadenosine tetraphosphate (AP4A) in human and animal cardiac preparations. J Pharmacol Exp Ther 288:805–813
Balogh J, Wihlborg AK, Isackson H et al (2005) Phospholipase C and cAMP-dependent positive inotropic effects of ATP in mouse cardiomyocytes via P2Y11-like receptors. J Mol Cell Cardiol 39:223–230
Flitney FW, Singh J (1980) Inotropic responses of the frog ventricle to adenosine triphosphate and related changes in endogenous cyclic nucleotides. J Physiol 304:21–42
Puceat M, Bony C, Jaconi M et al (1998) Specific activation of adenylyl cyclase V by a purinergic agonist. FEBS Lett 431:189–194
Communi D, Govaerts C, Parmentier M et al (1997) Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem 272:31969–31973
Communi D, Robaye B, Boeynaems JM (1999) Pharmacological characterization of the human P2Y11 receptor. Br J Pharmacol 128:1199–1206
Zambon AC, Hughes RJ, Meszaros JG et al (2000) P2Y2 receptor of MDCK cells: cloning, expression, and cell-specific signaling. Am J Physiol Renal Physiol 279:F1045–F1052
Hou M, Malmsjö M, Möller S et al (1999) Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure. Life Sci 65:1195–1206
Froldi G, Varani K, Chinellato A et al (1997) P2X-purinoceptors in the heart: actions of ATP and UTP. Life Sci 60:1419–1430
Froldi G, Ragazzi E, Caparrotta L (2001) Do ATP and UTP involve cGMP in positive inotropism on rat atria? Comp Biochem Physiol C Toxicol Pharmacol 128:265–274
Erlinge D, Harnek J, van Heusden C et al (2005) Uridine triphosphate (UTP) is released during cardiac ischemia. Int J Cardiol 100:427–433
Borna C, Lazarowski E, van Heusden C et al (2005) Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels. Thromb J 3:10
Kittel A, Kiss AL, Müllner N et al (2005) Expression of NTPDase1 and caveolins in human cardiovascular disease. Histochem Cell Biol 124:51–59
Gunduz D, Kasseckert SA, Härtel FV et al (2006) Accumulation of extracellular ATP protects against acute reperfusion injury in rat heart endothelial cells. Cardiovasc Res 71:764–773
Pham TM, Morris JB, Arthur JF et al (2003) UTP but not ATP causes hypertrophic growth in neonatal rat cardiomyocytes. J Mol Cell Cardiol 35:287–292
Zheng JS, Boluyt MO, O’Neill L et al (1994) Extracellular ATP induces immediate-early gene expression but not cellular hypertrophy in neonatal cardiac myocytes. Circ Res 74:1034–1041
Morris JB, Pham TM, Kenney B et al (2004) UTP transactivates epidermal growth factor receptors and promotes cardiomyocyte hypertrophy despite inhibiting transcription of the hypertrophic marker gene, atrial natriuretic peptide. J Biol Chem 279:8740–8746
Yitzhaki S, Shneyvays V, Jacobson KA et al (2005) Involvement of uracil nucleotides in protection of cardiomyocytes from hypoxic stress. Biochem Pharmacol 69:1215–1223
Yitzhaki S, Shainberg A, Cheporko Y et al (2006) Uridine-5’-triphosphate (UTP) reduces infarct size and improves rat heart function after myocardial infarct. Biochem Pharmacol 72:949–955
Saini HK, Shao Q, Musat S et al (2005) Imidapril treatment improves the attenuated inotropic and intracellular calcium responses to ATP in heart failure due to myocardial infarction. Br J Pharmacol 144:202–211
Banfi C, Ferrario S, De Vincenti O et al (2005) P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFα and potential role in myocardial cell death. J Mol Cell Cardiol 39:929–939
Malmsjö M, Bergdahl A, Möller S et al (1999) Congestive heart failure induces downregulation of P2X1-receptors in resistance arteries. Cardiovasc Res 43:219–227
Yang A, Sonin D, Jones L et al (2004) A beneficial role of cardiac P2X4 receptors in heart failure: rescue of the calsequestrin overexpression model of cardiomyopathy. Am J Physiol Heart Circ Physiol 287:H1096–H1103
Horackova M, Huang MH, Armour JA (1994) Purinergic modulation of adult guinea pig cardiomyocytes in long term cultures and co-cultures with extracardiac or intrinsic cardiac neurones. Cardiovasc Res 28:673–679
Jiang L, Bardini M, Keogh A et al (2005) P2X1 receptors are closely associated with connexin 43 in human ventricular myocardium. Int J Cardiol 98:291–297
Gaarder A, Jonsen J, Laland S et al (1961) Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 192:531–532
Daniel JL, Dangelmaier C, Jin J et al (1998) Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 273:2024–2029
Jin J, Kunapuli SP (1998) Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 95:8070–8074
Jin J, Daniel JL, Kunapuli SP (1998) Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 273:2030–2034
Kunapuli SP, Dorsam RT, Kim S et al (2003) Platelet purinergic receptors. Curr Opin Pharmacol 3:175–180
Gachet C, Hechler B (2005) The platelet P2 receptors in thrombosis. Semin Thromb Hemost 31:162–167
Foster CJ, Prosser DM, Agans JM et al (2001) Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 107:1591–1598
Fabre JE, Nguyen M, Latour A et al (1999) Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 5:1199–1202
Leon C, Alex M, Klocke A et al (2004) Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood 103:594–600
Gachet C (2005) The platelet P2 receptors as molecular targets for old and new antiplatelet drugs. Pharmacol Ther 108:180–192
Leon C, Hechler B, Freund M et al (1999) Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor-null mice. J Clin Invest 104:1731–1737
Mahaut-Smith MP, Tolhurst G, Evans RJ (2004) Emerging roles for P2X1 receptors in platelet activation. Platelets 15:131–144
Birk AV, Leno E, Robertson HD et al (2003) Interaction between ATP and catecholamines in stimulation of platelet aggregation. Am J Physiol Heart Circ Physiol 284:H619–H625
Sévigny J, Sundberg C, Braun N et al (2002) Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood 99:2801–2809
Robson SC, Kaczmarek E, Siegel JB et al (1997) Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med 185:153–163
Koyamada N, Miyatake T, Candinas D et al (1996) Apyrase administration prolongs discordant xenograft survival. Transplantation 62:1739–1743
Imai M, Takigami K, Guckelberger O et al (2000) Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival. Transplantation 70:864–870
Mizumoto N, Kumamoto T, Robson SC et al (2002) CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 8:358–365
Pearson JD (1993) The control of production and release of haemostatic factors in the endothelial cell. Baillieres Clin Haematol 6:629–651
Bouchie JL, Chen HC, Carney R et al (2000) P2Y receptor regulation of PAI-1 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20:866–873
CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet 348:1329–1339
Mehta SR, Yusuf S, Peters RJ et al (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358:527–533
Payne DA, Jones CI, Hayes PD et al (2004) Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation 109:1476–1481
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4